Prizes

• Nominated for the Prof. Bert Leufkens PhD thesis award 2022 (Utrecht Institute for Pharmaceutical Sciences): Evidence generation on benefits and risks of medicines and its impact on regulatory and downstream decision-making (PhD thesis)
• Editor's Pick May 2022 (British Journal of Clinical Pharmacology): Pre-approval and post-approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: a comparison with standard approved cancer drugs